Article Text

other Versions

Download PDFPDF
One prescription for the opioid crisis: require buprenorphine waivers for pain medicine fellows

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.


  • Contributors Both authors contributed in a substantial way to the conception or design of the work, the acquisition, analysis and interpretation of data; drafting the work or revising it critically for important intellectual content; final approval of the version published; and agreement to be accountable for all aspects of the work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests The first author serves on the advisory boards of Axial Healthcare and Alosa and has stock options in Axial Healthcare. He serves on the board of directors for the Association of Pain Program Directors. These arrangements have been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles